The road to discovery and innovation can be long and tough. 
Let us iron out the bends.

Because we can.


PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene's patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical  translational research and biomarker development.

PamGene is an innovator in the field of personalized medicine. In summary, use of our technology and products aim to help to create better medicines and help to pre-select patients that actually have benefit from the medicne. In order to achieve this in practice we​ support
  • research groups to discover new drug targets, optimise lead compounds and understand the mechanism of action of these compounds using cell line models.
  • toxicology groups with mechanistic tox studies and classical tox studies in an attempt to replace certain animal testing
  • translational biomarker groups in their goal to deliver leads and relevant PD and classification biomarkers to the clinic
  • patient classification for clinical trials.
We hope this information transfers some of our enthusiasm to you and that it will encourage you to further investigate the information on this website as well as contacting us to discuss your particular research question. We collaborate in many different ways and hope to welcome you soon as a partner in innovating medicine development!

Through information provided on our website, we hope you will discover the added value of PamGene's approach, the extensive application possibilities and our broad network of collaborators. We will gladly answer all your questions!